Zenotech Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹54.6
- Today's High:
- ₹58.7
- Open Price:
- ₹56.38
- 52W Low:
- ₹45
- 52W High:
- ₹77.8
- Prev. Close:
- ₹58.48
- Volume:
- 34875
Company Statistics
- Market Cap.:
- ₹2.09 billion
- Book Value:
- 7.734
- Revenue TTM:
- ₹197.22 million
- Operating Margin TTM:
- -13.46%
- Gross Profit TTM:
- ₹254.34 million
- Profit Margin:
- 22.08%
- Return on Assets TTM:
- -1.8%
- Return on Equity TTM:
- 9.68%
Company Profile
Zenotech Laboratories Limited had its IPO on under the ticker symbol 532039.
The company operates in the Other sector and Other industry. Zenotech Laboratories Limited has a staff strength of 123 employees.
Stock update
Shares of Zenotech Laboratories Limited opened at ₹56.38 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹54.6 - ₹58.7, and closed at ₹55.46.
This is a -5.16% slip from the previous day's closing price.
A total volume of 34,875 shares were traded at the close of the day’s session.
In the last one week, shares of Zenotech Laboratories Limited have slipped by -0.89%.
Zenotech Laboratories Limited's Key Ratios
Zenotech Laboratories Limited has a market cap of ₹2.09 billion, indicating a price to book ratio of 3.6252 and a price to sales ratio of 8.7218.
In the last 12-months Zenotech Laboratories Limited’s revenue was ₹197.22 million with a gross profit of ₹254.34 million and an EBITDA of ₹29.86 million. The EBITDA ratio measures Zenotech Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Zenotech Laboratories Limited’s operating margin was -13.46% while its return on assets stood at -1.8% with a return of equity of 9.68%.
In Q3, Zenotech Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 58.8%.
Zenotech Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 38.8889
- PEG
Its diluted EPS in the last 12-months stands at ₹0.709 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zenotech Laboratories Limited’s profitability.
Zenotech Laboratories Limited stock is trading at a EV to sales ratio of 9.6568 and a EV to EBITDA ratio of 17.4167. Its price to sales ratio in the trailing 12-months stood at 8.7218.
Zenotech Laboratories Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.01 billion
- Total Liabilities
- ₹166.07 million
- Operating Cash Flow
- ₹-58244000.00
- Capital Expenditure
- ₹62.32 million
- Dividend Payout Ratio
- 0%
Zenotech Laboratories Limited ended 2024 with ₹1.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.01 billion while shareholder equity stood at ₹822.70 million.
Zenotech Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹166.07 million in other current liabilities, 610306000.00 in common stock, ₹212.40 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹111.42 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
Zenotech Laboratories Limited’s total current assets stands at ₹162.65 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹33.24 million compared to accounts payable of ₹0 and inventory worth ₹0.00.
In 2024, Zenotech Laboratories Limited's operating cash flow was ₹-58244000.00 while its capital expenditure stood at ₹62.32 million.
Comparatively, Zenotech Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹55.46
- 52-Week High
- ₹77.8
- 52-Week Low
- ₹45
- Analyst Target Price
- ₹
Zenotech Laboratories Limited stock is currently trading at ₹55.46 per share. It touched a 52-week high of ₹77.8 and a 52-week low of ₹77.8. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹55.54 and 200-day moving average was ₹55.93 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 8479.3% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Zenotech Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Zenotech Laboratories Limited operates as a pharmaceutical specialty generic injectables company in India. The company manufactures oncology, biotechnology, and general injectable products, such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio primarily serves therapy areas, such as oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.